Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-08-20 Sale |
2024-08-22 8:01 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,000 | $280 | $4,200,000 | 76,200 (Indirect Direct) |
View |
2024-08-12 Sale |
2024-08-14 4:12 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
22,025 | $270.99 | $5,968,516 | 15,610 (Indirect Direct) |
View |
2024-08-06 Sale |
2024-08-08 4:10 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
20,250 | $262 | $5,305,586 | 3,636 (Indirect Direct) |
View |
2024-08-01 Sale |
2024-08-02 8:01 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,148 | $270 | $4,089,960 | 91,200 (Indirect Direct) |
View |
2024-07-11 Sale |
2024-07-12 8:02 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
7,093 | $261 | $1,851,273 | 73,848 (Indirect Direct) |
View |
2024-06-25 Sale |
2024-06-27 4:04 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
8,500 | $240 | $2,040,000 | 11,186 (Direct) |
View |
2024-06-24 Sale |
2024-06-26 4:28 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
32,450 | $220.69 | $7,161,360 | 43,086 (Indirect Direct) |
View |
2024-06-25 Sale |
2024-06-26 4:28 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
2,103 | $230.99 | $485,773 | 16,290 (Indirect Direct) |
View |
2024-06-25 Sale |
2024-06-26 4:27 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
8,301 | $230.99 | $1,917,475 | 80,941 (Indirect Direct) |
View |
2024-06-25 Sale |
2024-06-26 4:26 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,605 | $231 | $370,747 | 28,949 (Indirect Direct) |
View |
2024-06-25 Sale |
2024-06-26 4:26 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
1,605 | $231 | $370,747 | 11,660 (Direct) |
View |
2024-06-25 Sale |
2024-06-26 4:26 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
1,198 | $230.99 | $276,731 | 14,718 (Indirect Direct) |
View |
2024-05-29 Sale |
2024-05-31 7:00 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
21,700 | $148.6 | $3,224,546 | 8,436 (Direct) |
View |
2024-02-29 Sale |
2024-03-01 4:12 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
30,000 | $151.34 | $4,540,071 | 266,899 (Indirect Direct) |
View |
2024-02-28 Sale |
2024-02-29 4:18 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
501 | $155.3 | $77,805 | 8,569 (Direct) |
View |
2024-02-28 Sale |
2024-02-29 4:18 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
574 | $155.3 | $89,145 | 23,351 (Indirect Direct) |
View |
2024-02-28 Sale |
2024-02-29 4:18 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
2,932 | $155.31 | $455,357 | 60,377 (Indirect Direct) |
View |
2024-02-28 Sale |
2024-02-29 4:17 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
574 | $155.3 | $89,145 | 13,163 (Indirect Direct) |
View |
2024-02-28 Sale |
2024-02-29 4:16 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
329 | $155.3 | $51,094 | 5,887 (Direct) |
View |
2024-02-16 Sale |
2024-02-20 4:09 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,308 | $148.06 | $193,666 | 8,013 (Indirect Direct) |
View |
2024-02-16 Sale |
2024-02-20 4:08 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,007 | $148.06 | $149,099 | 18,201 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-10-08 Option Award |
2024-10-10 4:06 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
96 | $0 | 16,386 (Direct) |
View |
2024-10-01 Option Award |
2024-10-03 4:11 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Hesslein Robert W. EVP, CLO and Secretary |
7,245 | $0 | 7,245 (Direct) |
View |
2024-08-20 Exercise |
2024-08-22 8:01 pm |
N/A 2029-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,000 | $0 | 76,200 (Direct) |
View |
2024-08-20 Exercise |
2024-08-22 8:01 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,000 | $85 | 76,200 (Direct) |
View |
2024-08-12 Exercise |
2024-08-14 4:12 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
6,667 | $97.72 | 15,610 (Direct) |
View |
2024-08-12 Exercise |
2024-08-14 4:12 pm |
N/A 2029-02-28 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
20,725 | $0 | 15,610 (Direct) |
View |
2024-08-12 Exercise |
2024-08-14 4:12 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
14,058 | $85 | 15,610 (Direct) |
View |
2024-08-06 Exercise |
2024-08-08 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
9,000 | $105.26 | 3,636 (Direct) |
View |
2024-08-06 Exercise |
2024-08-08 4:10 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
11,250 | $131.21 | 3,636 (Direct) |
View |
2024-08-06 Exercise |
2024-08-08 4:10 pm |
2019-06-20 2028-06-19 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
20,250 | $0 | 3,636 (Direct) |
View |
2024-08-01 Exercise |
2024-08-02 8:01 pm |
N/A 2029-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,148 | $0 | 91,200 (Direct) |
View |
2024-08-01 Exercise |
2024-08-02 8:01 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
15,148 | $85 | 91,200 (Direct) |
View |
2024-06-25 Exercise |
2024-06-27 4:04 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
8,500 | $131.21 | 11,186 (Direct) |
View |
2024-06-25 Exercise |
2024-06-27 4:04 pm |
2016-06-01 2025-06-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
8,500 | $0 | 11,186 (Direct) |
View |
2024-06-24 Exercise |
2024-06-26 4:28 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
17,560 | $88.95 | 43,086 (Direct) |
View |
2024-06-24 Exercise |
2024-06-26 4:28 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,470 | $71.99 | 43,086 (Direct) |
View |
2024-06-24 Exercise |
2024-06-26 4:28 pm |
2017-06-03 2026-06-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
32,450 | $0 | 43,086 (Direct) |
View |
2024-06-24 Exercise |
2024-06-26 4:28 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
7,420 | $70.2 | 43,086 (Direct) |
View |
2024-06-24 Option Award |
2024-06-26 4:28 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
4,295 | $0 | 16,290 (Direct) |
View |
2024-06-24 Option Award |
2024-06-26 4:27 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
16,953 | $0 | 80,941 (Direct) |
View |
2024-06-24 Option Award |
2024-06-26 4:26 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,278 | $0 | 28,949 (Direct) |
View |
2024-06-24 Option Award |
2024-06-26 4:26 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
3,278 | $0 | 11,660 (Direct) |
View |
2024-06-24 Option Award |
2024-06-26 4:26 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,498 | $0 | 14,718 (Direct) |
View |
2024-05-29 Exercise |
2024-05-31 7:00 pm |
N/A 2024-07-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
30,000 | $0 | 8,436 (Direct) |
View |
2024-05-29 Exercise |
2024-05-31 7:00 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
30,000 | $66.83 | 8,436 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:11 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:10 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | KELLOGG PETER N Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:09 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Bertozzi Carolyn R Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:08 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:07 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BRANDICOURT OLIVIER Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:06 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | HAMBURG MARGARET A Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:06 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:05 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:04 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:03 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director |
5,228 | $0 | 5,228 (Direct) |
View |
2024-05-16 Option Award |
2024-05-20 4:02 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
5,228 | $0 | 5,228 (Direct) |
View |
Ownership |
2024-03-28 4:17 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
0 | $0 | 124,620 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 4:22 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
14,030 | $0 | 19,266 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 4:21 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
14,030 | $0 | 23,377 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 4:21 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
22,859 | $0 | 42,394 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 4:20 pm |
N/A 2034-03-01 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
70,148 | $0 | 118,683 (Direct) |
View |
2024-02-29 Exercise |
2024-03-01 4:12 pm |
2015-06-05 2024-06-04 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
30,000 | $0 | 266,899 (Direct) |
View |
2024-02-29 Exercise |
2024-03-01 4:12 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director |
30,000 | $59.25 | 266,899 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 4:18 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer |
1,667 | $0 | 8,569 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 4:18 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
1,908 | $0 | 23,351 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 4:18 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer |
5,921 | $0 | 60,377 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 4:17 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
1,908 | $0 | 13,163 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 4:16 pm |
N/A 2026-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
878 | $0 | 5,887 (Direct) |
View |
2024-02-15 Option Award |
2024-02-20 4:09 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs |
4,295 | $0 | 8,013 (Direct) |
View |
2024-02-15 Option Award |
2024-02-20 4:08 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer |
3,278 | $0 | 18,201 (Direct) |
View |